COGT logo

Cogent Biosciences, Inc. (COGT) EBITDA

annual EBITDA:

-$271.59M-$67.05M(-32.78%)
December 31, 2024

Summary

  • As of today (July 27, 2025), COGT annual EBITDA is -$271.59 million, with the most recent change of -$67.05 million (-32.78%) on December 31, 2024.
  • During the last 3 years, COGT annual EBITDA has fallen by -$198.03 million (-269.21%).
  • COGT annual EBITDA is now -4134.96% below its all-time high of -$6.41 million, reached on December 31, 2015.

Performance

COGT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

quarterly EBITDA:

-$73.80M-$1.17M(-1.61%)
March 31, 2025

Summary

  • As of today (July 27, 2025), COGT quarterly EBITDA is -$73.80 million, with the most recent change of -$1.17 million (-1.61%) on March 31, 2025.
  • Over the past year, COGT quarterly EBITDA has dropped by -$12.46 million (-20.31%).
  • COGT quarterly EBITDA is now -2989.39% below its all-time high of $2.55 million, reached on December 31, 2019.

Performance

COGT quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

TTM EBITDA:

-$284.05M-$12.46M(-4.59%)
March 31, 2025

Summary

  • As of today (July 27, 2025), COGT TTM EBITDA is -$284.05 million, with the most recent change of -$12.46 million (-4.59%) on March 31, 2025.
  • Over the past year, COGT TTM EBITDA has dropped by -$60.68 million (-27.17%).
  • COGT TTM EBITDA is now -4804.94% below its all-time high of -$5.79 million, reached on March 31, 2017.

Performance

COGT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

COGT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-32.8%-20.3%-27.2%
3 y3 years-269.2%-139.1%-210.0%
5 y5 years-779.4%-1162.3%-1183.7%

COGT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-269.2%at low-122.9%+0.7%-157.2%at low
5 y5-year-779.4%at low-936.9%+0.7%-1280.5%at low
alltimeall time-4135.0%at low-2989.4%+0.7%-4804.9%at low

COGT EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$73.80M(+1.6%)
-$284.05M(+4.6%)
Dec 2024
-$271.59M(+32.8%)
-$72.63M(-2.3%)
-$271.59M(+5.9%)
Sep 2024
-
-$74.32M(+17.4%)
-$256.40M(+6.5%)
Jun 2024
-
-$63.31M(+3.2%)
-$240.80M(+7.8%)
Mar 2024
-
-$61.34M(+6.8%)
-$223.37M(+9.2%)
Dec 2023
-$204.54M(+44.1%)
-$57.43M(-2.2%)
-$204.54M(+7.7%)
Sep 2023
-
-$58.73M(+28.0%)
-$189.92M(+15.6%)
Jun 2023
-
-$45.87M(+7.9%)
-$164.30M(+7.0%)
Mar 2023
-
-$42.51M(-0.7%)
-$153.62M(+8.2%)
Dec 2022
-$141.96M(+93.0%)
-$42.81M(+29.3%)
-$141.96M(+14.3%)
Sep 2022
-
-$33.11M(-5.9%)
-$124.25M(+12.5%)
Jun 2022
-
-$35.19M(+14.0%)
-$110.44M(+20.5%)
Mar 2022
-
-$30.86M(+23.0%)
-$91.64M(+24.6%)
Dec 2021
-$73.56M(+112.8%)
-$25.09M(+30.0%)
-$73.56M(+22.8%)
Sep 2021
-
-$19.30M(+17.9%)
-$59.91M(+18.0%)
Jun 2021
-
-$16.38M(+28.1%)
-$50.77M(+22.3%)
Mar 2021
-
-$12.78M(+11.7%)
-$41.51M(+20.1%)
DateAnnualQuarterlyTTM
Dec 2020
-$34.57M(+11.9%)
-$11.44M(+12.5%)
-$34.57M(+68.0%)
Sep 2020
-
-$10.17M(+42.9%)
-$20.58M(-7.0%)
Jun 2020
-
-$7.12M(+21.7%)
-$22.13M(-12.3%)
Mar 2020
-
-$5.85M(-328.9%)
-$25.22M(-18.3%)
Dec 2019
-$30.89M(-11.0%)
$2.55M(-121.8%)
-$30.89M(-26.6%)
Sep 2019
-
-$11.72M(+14.8%)
-$42.09M(+3.6%)
Jun 2019
-
-$10.21M(-11.3%)
-$40.62M(+2.8%)
Mar 2019
-
-$11.51M(+33.0%)
-$39.52M(+14.0%)
Dec 2018
-$34.68M(+38.8%)
-$8.65M(-15.6%)
-$34.68M(+6.4%)
Sep 2018
-
-$10.25M(+12.4%)
-$32.60M(+11.6%)
Jun 2018
-
-$9.11M(+36.6%)
-$29.23M(+13.0%)
Mar 2018
-
-$6.67M(+1.5%)
-$25.86M(+3.5%)
Dec 2017
-$24.98M(+37.0%)
-$6.57M(-4.3%)
-$24.98M(+35.7%)
Sep 2017
-
-$6.87M(+19.5%)
-$18.41M(+59.5%)
Jun 2017
-
-$5.75M(-0.8%)
-$11.54M(+99.2%)
Mar 2017
-
-$5.79M
-$5.79M
Dec 2016
-$18.24M(+184.4%)
-
-
Dec 2015
-$6.41M
-
-

FAQ

  • What is Cogent Biosciences, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. annual EBITDA year-on-year change?
  • What is Cogent Biosciences, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. quarterly EBITDA year-on-year change?
  • What is Cogent Biosciences, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. TTM EBITDA year-on-year change?

What is Cogent Biosciences, Inc. annual EBITDA?

The current annual EBITDA of COGT is -$271.59M

What is the all time high annual EBITDA for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high annual EBITDA is -$6.41M

What is Cogent Biosciences, Inc. annual EBITDA year-on-year change?

Over the past year, COGT annual EBITDA has changed by -$67.05M (-32.78%)

What is Cogent Biosciences, Inc. quarterly EBITDA?

The current quarterly EBITDA of COGT is -$73.80M

What is the all time high quarterly EBITDA for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high quarterly EBITDA is $2.55M

What is Cogent Biosciences, Inc. quarterly EBITDA year-on-year change?

Over the past year, COGT quarterly EBITDA has changed by -$12.46M (-20.31%)

What is Cogent Biosciences, Inc. TTM EBITDA?

The current TTM EBITDA of COGT is -$284.05M

What is the all time high TTM EBITDA for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high TTM EBITDA is -$5.79M

What is Cogent Biosciences, Inc. TTM EBITDA year-on-year change?

Over the past year, COGT TTM EBITDA has changed by -$60.68M (-27.17%)
On this page